HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Boekhoorn, S. S. Articles by de Jong, P. T. V. M. Search for Related Content PubMed PubMed Citation Articles by Boekhoorn, S. S. Articles by de Jong, P. T. V. M.

Estrogen Receptor Gene Polymorphisms Associated with Incident Aging Macula Disorder

¹From the Departments of Epidemiology and Biostatistics, ²Ophthalmology, and ³Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; ⁴The Netherlands Institute for Neuroscience, KNAW, Amsterdam, The Netherlands; and the ⁵Department of Ophthalmology, Academic Medical Center, Amsterdam, The Netherlands.

PURPOSE. It has been suggested that early menopause increases the risk of aging-macula disorder (AMD), the major cause of incurable blindness with a dry and wet late subtype, and that exposure to endogenous or postmenopausal exogenous estrogens reduces this risk. This study was undertaken to investigate whether genetic variations in the estrogen receptor (ESR1) gene are associated with incident AMD.

METHODS. In the Rotterdam Study, a prospective population-based cohort study of participants aged 55 years and older, associations between ESR1 PvuII-XbaI haplotypes and incident early or late AMD were studied in 4571 participants after a mean follow-up time of 7.7 years. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs), with adjustment for the most common confounders.

RESULTS. ESR1 PvuII-XbaI haplotype 1 was a risk factor for late AMD. Persons with two copies of haplotype 1 were at 3.20 (95% CI, 1.47–6.99) times higher risk for late AMD than noncarriers of haplotype 1, after adjustment for age and sex. This increase was more pronounced for wet AMD (hazard ratio [HR] 4.29; 95% CI, 1.47–12.49) after adjustment for age, sex, smoking, and complement factor H genotype. Correction for additional confounders, including age at menopause, use of hormone replacement therapy, blood pressure, and body mass index did not essentially alter the findings.

CONCLUSIONS. Persons with one or two copies of ESR1 PvuII-XbaI haplotype 1 have an increased risk of late AMD, especially of the wet form.

This article has been cited by other articles:

				R. L. Seitzman, V. B. Mahajan, C. Mangione, J. A. Cauley, K. E. Ensrud, K. L. Stone, S. R. Cummings, M. C. Hochberg, T. A. Hillier, J. S. Sinsheimer, et al. Estrogen Receptor Alpha and Matrix Metalloproteinase 2 Polymorphisms and Age-related Maculopathy in Older Women Am. J. Epidemiol., May 15, 2008; 167(10): 1217 - 1225. [Abstract] [Full Text] [PDF]

				M. J. Kanis, R. P. L. Wisse, T. T. J. M. Berendschot, J. van de Kraats, and D. van Norren Foveal Cone-Photoreceptor Integrity in Aging Macula Disorder Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2077 - 2081. [Abstract] [Full Text] [PDF]